Important information for properly prescribing RYBELSUS®.
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
aThe 3-mg dose is intended for treatment initiation and is not effective for glycemic control.
Be sure your patients understand how to take RYBELSUS®, in order for the medication to work as intended.
The blister pack helps to protect the tablet, so patients will need to follow specific instructions for use.
Store at room temperature 68°F–77°F (20°C–25°C).
Patients must take RYBELSUS® on an empty stomach
Patients should take RYBELSUS® with a sip of plain water
Waiting less than 30 minutes or taking with food, beverages (other than plain water), or other oral medications will lessen the effect of RYBELSUS®. Waiting more than 30 minutes to eat may increase the absorption of RYBELSUS®
This digital guide gives your patients information on how to start and details on what to expect after their initial 30 days. It also provides proper storage and savings program information.
Learn how to accurately capture RYBELSUS® in your EHR to ePrescribe for your appropriate patients. Download instructions for future reference.
aThe 3-mg dose is intended for treatment initiation and is not effective for glycemic control.
bThese are intended only as a guide for your reference and do not substitute for instructions provided by your EHR vendor/manufacturer. Please contact your practice EHR IT support team with any questions about your system.
Request a patient starter kit for your patients. Each kit includes information about a savings offer that could help with the cost of their prescriptions.
You may also be interested in:
WARNING: RISK OF THYROID C-CELL TUMORS
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
WARNING: RISK OF THYROID C-CELL TUMORS
Please click here for Prescribing Information, including Boxed Warning.
Reference: